139 related articles for article (PubMed ID: 944026)
1. A behavioral paradigm for the evaluation of narcotic antagonists.
Meyer RE; Mirin SM; Altman JL; McNamee HB
Arch Gen Psychiatry; 1976 Mar; 33(3):371-7. PubMed ID: 944026
[TBL] [Abstract][Full Text] [Related]
2. Analysis and modification of opiate reinforcement.
Meyer RE; McNamee HB; Mirin SM; Altman JL
Int J Addict; 1976; 11(3):467-84. PubMed ID: 184053
[TBL] [Abstract][Full Text] [Related]
3. The clinical usefulness of narcotic antagonists: implications of behavioral research.
Meyer RE; Mirin SM; Altman JL
Am J Drug Alcohol Abuse; 1975; 2(3-4):417-32. PubMed ID: 179316
[No Abstract] [Full Text] [Related]
4. Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study.
Altman JL; Meyer RE; Mirin SM; McNamee HB
Int J Addict; 1976; 11(3):485-99. PubMed ID: 184054
[TBL] [Abstract][Full Text] [Related]
5. Methadone maintenance and narcotic blocking drugs.
Wikler A
Int J Addict; 1977 Oct; 12(7):851-6. PubMed ID: 201577
[TBL] [Abstract][Full Text] [Related]
6. Methadone maintenance and narcotic blocking drugs. Appendix.
Wikler A
Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
[TBL] [Abstract][Full Text] [Related]
7. NIDA's naltrexone research program.
Julius D
NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
[No Abstract] [Full Text] [Related]
8. Limitations of an extinction approach to narcotic antagonist treatment.
Meyer R; Randall R; Barrington C; Mirin S; Greenberg I
NIDA Res Monogr; 1976 Sep; (9):123-35. PubMed ID: 187940
[No Abstract] [Full Text] [Related]
9. Aftercare on narcotic antagonists: prospects and problems.
Rawlins M; Randall M
Int J Addict; 1976; 11(3):501-11. PubMed ID: 184055
[TBL] [Abstract][Full Text] [Related]
10. Narcotic antagonists: naltrexone progress report: foreword.
Jaffe J
NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
[No Abstract] [Full Text] [Related]
11. Narcotic antagonists in the treatment of opioid dependence: review and commentary.
Resnick RB; Schuyten-Resnick E; Washton AM
Compr Psychiatry; 1979; 20(2):116-25. PubMed ID: 421447
[No Abstract] [Full Text] [Related]
12. Treatment of heroin-dependent persons with antagonists: current status.
Renault PF
NIDA Res Monogr; 1981; 28():11-22. PubMed ID: 6791000
[TBL] [Abstract][Full Text] [Related]
13. [The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts].
Yang G; Zhou W; Xu K
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):679-82. PubMed ID: 11715458
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
[TBL] [Abstract][Full Text] [Related]
15. Narcotic antagonists: a reasonable method of treating narcotic dependency.
Schooff KG; Hersch RG; Keegan JF
Int J Addict; 1975; 10(3):391-400. PubMed ID: 170227
[TBL] [Abstract][Full Text] [Related]
16. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
Martin WR
NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
[No Abstract] [Full Text] [Related]
17. Pharmacological adjuncts in the treatment of opiate dependence.
Resnick RB
Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
[No Abstract] [Full Text] [Related]
18. [Management of opium addicts using opiates and their antagonists].
Burchard JM
Nervenarzt; 1972 Oct; 43(10):501-4. PubMed ID: 4564819
[No Abstract] [Full Text] [Related]
19. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
[No Abstract] [Full Text] [Related]
20. Evolution of the National Academy of Sciences study of naltrexone.
Kaim SC
NIDA Res Monogr; 1976 Sep; (9):37-44. PubMed ID: 794719
[No Abstract] [Full Text] [Related]
[Next] [New Search]